References
- EMCDDA. Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation. 2018 [cited 2018 Jun 19]. Available from: http://www.emcdda.europa.eu/system/files/publications/8870/2018-2489-td0118414enn.pdf
- Lust EB, Barthold C, Malesker MA, et al. Human health hazards of veterinary medications: information for emergency departments. J Emerg Med. 2011;40:198–207.
- EMCDDA. EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 1-(2-phenylethyl)-4 [phenyl(propanoyl)amino]piperidine-4-carboxylate (carfentanil). 2017 [cited 2018 Jun 19]. Available from: http://www.emcdda.europa.eu/publications/joint-reports/carfentanil_en
- Helander A, Bäckberg M. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs. Clin Toxicol. 2017;55:1–3.
- Sofalvi S, Schueler HE, Lavins ES, et al. An LC-MS-MS method for the analysis of carfentanil, 3-methylfentanyl, 2-furanyl fentanyl, acetyl fentanyl, fentanyl and norfentanyl in postmortem and impaired-driving cases. J Anal Toxicol. 2017;41:473–483.